Clinical trial
Effects of Buspirone in Opiate Withdrawal
NCT00326235 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00326235 |
|---|---|
| Title | Effects of Buspirone in Opiate Withdrawal |
| Official title | Effects of Buspirone in Withdrawal From Opiates |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heroin Dependence |
| Intervention type | Drug |
| Interventions | Buspirone |
| Start date | Jan 1, 2002 |
| Completion | Jul 1, 2004 |
| First posted | May 16, 2006 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: